deutrino is a user on mstdn.io. You can follow them or interact with them if you have an account anywhere in the fediverse.
If you don't, you can sign up here.
Deep dive on the pros & cons of using IBM's #Watson to help treat cancer, and the huge challenges involved: https://www.statnews.com/2017/09/05/watson-ibm-cancer/
tl;dr: it's still in its infancy, basically Sloan-Kettering Cancer Center in a box (with docs from there feeding it all it knows sort of like Mechanical Turk workers), with all the problems and biases that implies, but it's got a lot of promise treating people in areas with no oncology experts
